Intrathecal morphine tolerance: use of intrathecal clonidine, DADLE, and intraventricular morphine.
D000230:Adenocarcinoma / Q000503:physiopathology; D002045:Bupivacaine / Q000008:administration & dosage; D003000:Clonidine / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D004743:Enkephalin, Leucine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016308:Enkephalin, Leucine-2-Alanine; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation; D007276:Injections, Intraventricular; D007278:Injections, Spinal / Q000295:instrumentation; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D009407:Nerve Block; D010148:Intractable Pain / Q000188:drug therapy*; D010386:Pelvic Neoplasms / Q000503:physiopathology; D013727:Terminal Care
D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D009020:Morphine; D003000:Clonidine; D002045:Bupivacaine